ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale
- PMID: 16096160
- DOI: 10.1080/13685530500163416
ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale
Abstract
Prescription sales for testosterone products have substantially increased over the last several years reflecting the growing awareness of physicians for the potential benefits of testosterone replacement therapy in men with hypogonadism. Indiscriminate administration of testosterone poses a risk and has to be deprecated. Testosterone supplementation to treat late-onset hypogonadism (LOH), a term for androgen deficiency in elderly men, is still controversially discussed mainly due to a lack of large, controlled clinical trials on efficacy and safety. To provide guidance for physicians primarily dealing with aging men, ISSAM is periodically updating and publishing its recommendations as new data become available [Morales A, Lunenfeld B. International Society for the Study of the Aging Male. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002;5:74-86 and Morales A, Lunenfeld B. Androgen replacement therapy in aging men with secondary hypogonadism. Draft recommendations for endorsement by ISSAM. Aging Male 2001;4:1]. Following a panel discussion at the 4th ISSAM Congress in Prague in February 2004, the International Society of Andrology (ISA), the International Society for the Study of the Aging Male (ISSAM) and the European Association of Urology (EAU) revised existing recommendations on the definition, diagnosis and management of LOH. The recommendations are based on the currently available scientific data on androgen supplementation therapy and should be regarded as provisional until larger-scale, long-term studies are available. While certainly not intending to be exhaustive, this review will highlight some relevant background information and provide the underlying scientific rationale for the ISA, ISSAM and EAU recommendations on LOH published in this issue.
Similar articles
-
Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male.Aging Male. 2002 Jun;5(2):74-86. Aging Male. 2002. PMID: 12198738 No abstract available.
-
Re: Christina Wang, Eberhard Nieschlag, Ronald Swerdloff, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol 2009;55:121-30.Eur Urol. 2009 May;55(5):e92; author reply e93-4. doi: 10.1016/j.eururo.2008.11.053. Epub 2008 Dec 4. Eur Urol. 2009. PMID: 19081175 No abstract available.
-
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.Int J Impot Res. 2009 Jan-Feb;21(1):1-8. doi: 10.1038/ijir.2008.41. Epub 2008 Oct 16. Int J Impot Res. 2009. PMID: 18923415 Review.
-
Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations.Eur Urol. 2005 Jul;48(1):1-4. doi: 10.1016/j.eururo.2005.04.027. Eur Urol. 2005. PMID: 15951102 No abstract available.
-
Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.J Endocrinol Invest. 2005;28(11 Suppl Proceedings):61-8. J Endocrinol Invest. 2005. PMID: 16760628 Review.
Cited by
-
Long-term testosterone replacement therapy reduces fatigue in men with hypogonadism.Drugs Context. 2022 Feb 2;11:2021-8-12. doi: 10.7573/dic.2021-8-12. eCollection 2022. Drugs Context. 2022. PMID: 35211178 Free PMC article.
-
Association between body fat distribution and androgen deficiency in middle-aged and elderly men in China.Int J Impot Res. 2014 May-Jun;26(3):116-9. doi: 10.1038/ijir.2013.48. Epub 2013 Dec 19. Int J Impot Res. 2014. PMID: 24352246
-
Role of sex hormone-binding globulin in the free hormone hypothesis and the relevance of free testosterone in androgen physiology.Cell Mol Life Sci. 2022 Oct 7;79(11):543. doi: 10.1007/s00018-022-04562-1. Cell Mol Life Sci. 2022. PMID: 36205798 Free PMC article. Review.
-
Reference Ranges and Association of Age and Lifestyle Characteristics with Testosterone, Sex Hormone Binding Globulin, and Luteinizing Hormone among 1166 Western Chinese Men.PLoS One. 2016 Oct 6;11(10):e0164116. doi: 10.1371/journal.pone.0164116. eCollection 2016. PLoS One. 2016. PMID: 27711240 Free PMC article.
-
Low serum testosterone increases mortality risk among male dialysis patients.J Am Soc Nephrol. 2009 Mar;20(3):613-20. doi: 10.1681/ASN.2008060664. Epub 2009 Jan 14. J Am Soc Nephrol. 2009. PMID: 19144759 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical